Full project customization from array selection (e.g., EPIC, 450K) to bespoke bioinformatics pipelines specifically tailored to unique disease cohorts, multi-omics integration requirements, or complex experimental designs.
Creative Biolabs' array based DNA methylation profiling service constitutes a highly scalable, high-quality, and economically efficient methodology for comprehensive epigenomic research. This offering encompasses the complete molecular profiling process, ranging from primary sample preparation on the Illumina platform to the generation of advanced bioinformatics reports. Research clients can thus anticipate the acquisition of highly reproducible methylation and CNV data, sophisticated molecular classification capabilities for their research cohorts, the identification of robust biomarkers suitable for predicting experimental outcomes, and access to customized analytical pipelines optimized for direct integration with machine learning methodologies.
DNA methylation constitutes a stable epigenetic modification crucial for gene regulation and is implicated in the pathogenesis of conditions across oncology and neurology. Array-based platforms are preferred for large epigenome-wide association studies (EWAS) due to their high reproducibility and superior cost-effectiveness compared to whole-genome bisulfite sequencing. Advanced applications include high-fidelity cross-species analysis and enhanced molecular classification via integrated copy number variation (CNV) detection and machine learning.
To explore the comprehensive capabilities of our services and determine project suitability, we encourage the immediate scheduling of a preliminary consultation.
Fig.1 Methods in DNA methylation array dataset analysis. 1
Full project customization from array selection (e.g., EPIC, 450K) to bespoke bioinformatics pipelines specifically tailored to unique disease cohorts, multi-omics integration requirements, or complex experimental designs.
Utilizing the standardized platform for unparalleled data reproducibility and generating high-quality, standardized data packages essential for validation studies and publication.
Simultaneous detection of differential methylated regions (DMRs) and large-scale copy number variations from a single assay, providing a comprehensive genomic and epigenomic view for superior disease classification.
Our proprietary pipeline incorporates state-of-the-art epigenetic deconvolution to accurately estimate and correct for cellular heterogeneity, ensuring the methylation values confidently reflect the cell type of interest (e.g., tumor purity).
Arrays offer unparalleled standardization, which is essential for generating high-quality, standardized data in large-scale translational studies. This scalability drastically reduces the cost per data point compared to sequencing alternatives.
Our service utilizes strategies that focus on highly conserved CpG sites, ensuring high-fidelity measurements in pre-clinical models (mouse, rat) that are highly correlative with human data, maximizing the probability that research leads successfully translate to human studies.
We go beyond simple methylation calls. Our established pipelines allow for robust molecular subtyping via powerful clustering methods and concurrent CNV calling, providing a comprehensive genomic and epigenomic view for superior disease classification.
Our standardized data output is optimized for use with state-of-the-art machine learning (ML) and neural network algorithms, enabling you to build and validate highly accurate outcomes and classification models.
Prospective partners are encouraged to formally engage with us to obtain a detailed service proposal.
Array profiling is highly recommended for large-scale studies where cost-effectiveness and standardization are paramount. While WGBS offers whole-genome coverage, array technology provides robust, quantitative data on millions of the most biologically and clinically relevant CpG sites, offering a lower cost per sample point and superior scalability for research cohorts.
We successfully process DNA from a wide range of sources, including fresh-frozen tissue, FFPE (formalin-fixed, paraffin-embedded) blocks, whole blood, and cell-free DNA (cfDNA). The key precaution is ensuring the starting DNA quantity meets the minimum requirement and passes our initial quality control checks.
Comprehensive genomic analysis of patient samples provides high-resolution identification of germline and somatic mutations, informing clinical decision support and personalized therapeutic strategies.
Learn More →Provides comprehensive, high-sensitivity detection of somatic variants, including SNVs, indels, and translocations, utilizing optimized NGS panels crucial for precision oncology and biomarker discovery.
Learn More →Creative Biolabs offers the gold standard in scalable, high-fidelity epigenomic analysis, providing validated biomarkers, mechanistic clarity, and the data necessary for advanced classification and outcomes modeling. We are your partner in translating complex epigenetic insights into robust discovery strategies. For detailed information, custom study design, and a complimentary consultation on how our array platform can revolutionize your research, please contact us.
Reference